About 3-[4-methyl-3-[[(4R)-4-methyl-1,1-dioxo-3,4-dihydro-5,1λ6,2-benzoxathiazepin-2-yl]methyl]phenyl]-5-(1-propan-2-yltriazol-4-yl)pentanoic acid
3-[4-methyl-3-[[(4R)-4-methyl-1,1-dioxo-3,4-dihydro-5,1λ6,2-benzoxathiazepin-2-yl]methyl]phenyl]-5-(1-propan-2-yltriazol-4-yl)pentanoic acid (PubChem CID 118170243) has the molecular formula C27H34N4O5S
and a molecular weight of 526.66 g/mol. Its IUPAC name is 3-[4-methyl-3-[[(4R)-4-methyl-1,1-dioxo-3,4-dihydro-5,1λ6,2-benzoxathiazepin-2-yl]methyl]phenyl]-5-(1-propan-2-yltriazol-4-yl)pentanoic acid.
Analyze 3-[4-methyl-3-[[(4R)-4-methyl-1,1-dioxo-3,4-dihydro-5,1λ6,2-benzoxathiazepin-2-yl]methyl]phenyl]-5-(1-propan-2-yltriazol-4-yl)pentanoic acid with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 3-[4-methyl-3-[[(4R)-4-methyl-1,1-dioxo-3,4-dihydro-5,1λ6,2-benzoxathiazepin-2-yl]methyl]phenyl]-5-(1-propan-2-yltriazol-4-yl)pentanoic acid?
The IUPAC name of 3-[4-methyl-3-[[(4R)-4-methyl-1,1-dioxo-3,4-dihydro-5,1λ6,2-benzoxathiazepin-2-yl]methyl]phenyl]-5-(1-propan-2-yltriazol-4-yl)pentanoic acid (CID 118170243) is 3-[4-methyl-3-[[(4R)-4-methyl-1,1-dioxo-3,4-dihydro-5,1λ6,2-benzoxathiazepin-2-yl]methyl]phenyl]-5-(1-propan-2-yltriazol-4-yl)pentanoic acid.
What is the SMILES notation for 3-[4-methyl-3-[[(4R)-4-methyl-1,1-dioxo-3,4-dihydro-5,1λ6,2-benzoxathiazepin-2-yl]methyl]phenyl]-5-(1-propan-2-yltriazol-4-yl)pentanoic acid?
The canonical SMILES for 3-[4-methyl-3-[[(4R)-4-methyl-1,1-dioxo-3,4-dihydro-5,1λ6,2-benzoxathiazepin-2-yl]methyl]phenyl]-5-(1-propan-2-yltriazol-4-yl)pentanoic acid is Cc1ccc(C(CCc2cn(C(C)C)nn2)CC(=O)O)cc1CN1C[C@@H](C)Oc2ccccc2S1(=O)=O.
What is the InChIKey of 3-[4-methyl-3-[[(4R)-4-methyl-1,1-dioxo-3,4-dihydro-5,1λ6,2-benzoxathiazepin-2-yl]methyl]phenyl]-5-(1-propan-2-yltriazol-4-yl)pentanoic acid?
The InChIKey is GNXFBTOJIPLCGB-PSDZMVHGSA-N. The full InChI is InChI=1S/C27H34N4O5S/c1-18(2)31-17-24(28-29-31)12-11-22(14-27(32)33)21-10-9-19(3)23(13-21)16-30-15-20(4)36-25-7-5-6-8-26(25)37(30,34)35/h5-10,13,17-18,20,22H,11-12,14-16H2,1-4H3,(H,32,33)/t20-,22?/m1/s1.
What are the key properties of 3-[4-methyl-3-[[(4R)-4-methyl-1,1-dioxo-3,4-dihydro-5,1λ6,2-benzoxathiazepin-2-yl]methyl]phenyl]-5-(1-propan-2-yltriazol-4-yl)pentanoic acid?
3-[4-methyl-3-[[(4R)-4-methyl-1,1-dioxo-3,4-dihydro-5,1λ6,2-benzoxathiazepin-2-yl]methyl]phenyl]-5-(1-propan-2-yltriazol-4-yl)pentanoic acid has a molecular weight of 526.66 g/mol, XLogP of 4.33, 9 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[4-methyl-3-[[(4R)-4-methyl-1,1-dioxo-3,4-dihydro-5,1λ6,2-benzoxathiazepin-2-yl]methyl]phenyl]-5-(1-propan-2-yltriazol-4-yl)pentanoic acid is sourced from PubChem (CID 118170243), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).